US Food and Drug Administration (FDA) cracks down on false claims--issuing warning letters to companies for marketing supplements as valid treatment options for Alzheimer’s disease.
US Food and Drug Administration (FDA) cracks down on false claims--issuing warning letters to companies for marketing supplements as valid treatment options for Alzheimer’s disease.
